Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study

Kroken, Rune A.; Johnsen, Erik; Ruud, Torleif; Wentzel-Larsen, Tore; Jørgensen, Hugo A
January 2009
BMC Psychiatry;2009, Vol. 9, Special section p1
Academic Journal
Background: Surveys on prescription patterns for antipsychotics in the Scandinavian public health system are scarce despite the prevalent use of these drugs. The clinical differences between antipsychotic drugs are mainly in the areas of safety and tolerability, and international guidelines for the treatment of schizophrenia offer rational strategies to minimize the burden of side effects related to antipsychotic treatment. The implementation of treatment guidelines in clinical practice have proven difficult to achieve, as reflected by major variations in the prescription patterns of antipsychotics between different comparable regions and countries. The objective of this study was to evaluate the practice of treatment of schizophrenic patients with antipsychotics at discharge from acute inpatient settings at a national level. Methods: Data from 486 discharges of patients from emergency inpatient treatment of schizophrenia were collected during a three-month period in 2005; the data were collected in a large national study that covered 75% of Norwegian hospitals receiving inpatients for acute treatment. Antipsychotic treatment, demographic variables, scores from the Global Assessment of Functioning and Health of the Nation Outcome Scales and information about comorbid conditions and prior treatment were analyzed to seek predictors for nonadherence to guidelines. Results: In 7.6% of the discharges no antipsychotic treatment was given; of the remaining discharges, 35.6% were prescribed antipsychotic polypharmacy and 41.9% were prescribed at least one first-generation antipsychotic (FGA). The mean chlorpromazine equivalent dose was 450 (SD 347, range 25-2800). In the multivariate regression analyses, younger age, previous inpatient treatment in the previous 12 months before index hospitalization, and a comorbid diagnosis of personality disorder or mental retardation predicted antipsychotic polypharmacy, while previous inpatient treatment in the previous 12 months also predicted prescription of at least one FGA. Conclusion: Our national survey of antipsychotic treatment at discharge from emergency inpatient treatment revealed antipsychotic drug regimens that are to some degree at odds with current guidelines, with increased risk of side effects. Patients with high relapse rates, comorbid conditions, and previous inpatient treatment are especially prone to be prescribed antipsychotic drug regimens not supported by international guidelines.


Related Articles

  • Benefits and Risks of Antipsychotic Polypharmacy: An Evidence-Based Review of the Literature. Tranulis, Constantin; Skalli, Leila; Lalonde, Pierre; Nicole, Luc; Stip, Emmanuel // Drug Safety;2008, Vol. 31 Issue 1, p7 

    Combination antipsychotic prescription is an increasingly common practice in clinical psychiatry. This clinical practice is at odds with clinical guidelines promoting antipsychotic monotherapy. Moreover, there has been increased concern over the safety profile of atypical antipsychotics in the...

  • Sertindole poisoning.  // Reactions Weekly;Apr2014, Vol. 1497 Issue 1, p35 

    The article presents a case study of a 29-year-old man diagnosed with various toxicities developed after sertindole poisoning.

  • Commentary on strategies for switching antipsychotics. Davis, John M.; Leucht, Stefan // BMC Medicine;2008, Vol. 6, Special section p1 

    Both the new generation of antipsychotics and the more traditional antipsychotic drugs produce an important and meaningful improvement in patients with schizophrenia, but most patients are neither cured nor free of symptoms. As a consequence, it is common to switch from one drug to another in...

  • Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype. Zhang, Yi; Chen, Meijuan; Chen, Jun; Wu, Zhiguo; Yu, Shunying; Fang, Yiru; Zhang, Chen // Psychopharmacology;May2014, Vol. 231 Issue 10, p2211 

    Rationale: Metabolic syndrome (MetS) has consistently been identified as an adverse effect of long-term treatment with atypical antipsychotics (AAPs) such as clozapine. Elevated serum homocysteine concentration has been found to act as an independent risk factor for MetS, and...

  • Combination of Aripiprazole and Other Psychopharmacological Treatments in Resistant and Multi-Resistant Patients. Cobo G�mez, Jes�s Vicente; Fuste, Gideoni; Coronas, Ram�n; Benito, Nagore; Barbero, Juan-David; Domenech, Cristina; Garc�a-Par�s, Gemma // Current Drug Safety;Sep2008, Vol. 3 Issue 3, p210 

    Introduction: Aripiprazole is a new antipsychotic agent that has proven safe and efficacious in controlled clinical trials. However, few published data on its effectiveness and safety when used in augmentation and combination are available. Methods: Our study aimed to determine the functional...

  • Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management. Haddad, Peter M.; Wieck, Angelika // Drugs;2004, Vol. 64 Issue 20, p2291 

    Hyperprolactinaemia is an important but neglected adverse effect of antipsychotic medication. It occurs frequently with conventional antipsychotics and some atypical antipsychotics (risperidone and amisulpride) but is rare with other atypical antipsychotics (aripiprazole, clozapine, olanzapine,...

  • Adverse Reaction Case Reports.  // Reactions Weekly;12/18/2004, Issue 1032, p6 

    Presents information on several case reports regarding drug adverse reactions. Information on neuroleptic malignant syndrome; Analysis of chronic carbamazepine toxicity; Development of acute hepatitis during treatment with cetirizine for seasonal-allergic-rhinitis.

  • Pancreatitis in a child: case report.  // Reactions Weekly;2/26/2005, Issue 1040, p15 

    Discusses a case report on the development of pancreatitis in a boy while receiving risperidone for aggressive behaviour. Dosage of risperidone given to the child daily; Symptoms developed by the patient after four weeks of medication; Condition of the patient when he was admitted to the hospital.

  • Multiple drugs overdose.  // Reactions Weekly;10/3/2009, Issue 1272, p24 

    The article reports on the cases of two female patients, who after taking overdoses of quetiapine, diazepam, ferrous fumarate and dihydrocodeine/paracetamol developed coma and QTc prolongation and tachycardic individually. Patient 1 was comatose upon admission and was given soya oil emulsion to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics